Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Other Non-Current Liabilities (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $871000.0 as the latest value for Q1 2023.

  • Quarterly Other Non-Current Liabilities changed N/A to $871000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $871000.0 through Mar 2023, changed N/A year-over-year, with the annual reading at $10.8 million for FY2022, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q1 2023 was $871000.0 at LENZ Therapeutics, down from $10.8 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $10.8 million in Q4 2022, with the low at $871000.0 in Q1 2023.